Safety and efficacy results of LIS1, a new induction treatment in organ transplantation by the French biotech XENOTHERA

Latest Posts

Perha Pharmaceuticals is a laureate of the European Innovation Council (EIC) Accelerator Programme and could receive an €8 M in funding for the development of its lead candidate Leucettinib-21

15 September 2022

Perha Pharmaceuticals has been selected by the European Commission under the European Innovation Council (EIC) Accelerator Programme for the development... View Article

Pherecydes Pharma announces a first registration of its phagogram as an in vitro diagnostic test in accordance with EC Directives

Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the registration... View Article

Naobios x GenSensor: a partnership for bioprocess optimization

A partnership between three members of Atlanpole Biotherapies: Naobios, Clean Biologics and GenSensor. The collaboration aims at bioprocess optimization through joint bioproduction expertise. Two companies providing expert... View Article

« Previous 1 … 9 10 11 12 13 … 160 Next »